Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 12/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 6/20 | 0.47 |
| ▸ | FLT1 | P17948 | 3/20 | 0.47 |
| ▸ | ABL1 | P00519 | 2/20 | 0.47 |
| ▸ | FYN | P06241 | 2/20 | 0.47 |
| ▸ | SRC | P12931 | 2/20 | 0.47 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.47 |
| ▸ | MAP3K1 | Q13233 | 2/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | MAP4K5 | Q9Y4K4 | 2/20 | 0.47 |
| ▸ | PLK4 | O00444 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.47 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.47 |
| ▸ | STK10 | O94804 | 1/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | INSR | P06213 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6445835 | 0.92 | KDR (0.48) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378159 | 0.91 | KDR (0.57) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378390 | 0.91 | KDR (0.48) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378671 | 0.90 | KDR (0.46) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378508 | 0.89 | KDR (0.48) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378651 | 0.88 | KDR (0.64) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378299 | 0.88 | KDR (0.46) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378491 | 0.87 | KDR (0.57) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL378418 | 0.86 | KDR (0.41) | KDRPDGFRBFLT1ABL1FYN | |
| SCHEMBL377926 | 0.86 | KDR (0.67) | KDRPDGFRBFLT1ABL1FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371298-B2 | Processes for the preparation of isothiazole derivatives | PFIZER INC. (US) | 2016-06-21 | — | — | US | claimed |
| US-20150065726-A1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER INC. | 2015-03-05 | — | — | US | claimed |
| EP-1784183-B1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER (US) | 2012-01-25 | — | — | EP | claimed |
| US-20090023924-A1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER INC. | 2009-01-22 | — | — | US | claimed |
| EP-1784183-A2 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | Pfizer Products Incorporated (US) | 2007-05-16 | — | — | EP | claimed |
| WO-2006026034-A2 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2006-03-09 | — | — | WO | claimed |
| US-9371298-B2 | Processes for the preparation of isothiazole derivatives | PFIZER INC. (US) | 2016-06-21 | — | — | US | disclosed |
| US-20150065726-A1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER INC. | 2015-03-05 | — | — | US | disclosed |
| US-8884025-B2 | Processes for the preparation of isothiazole derivatives | PFIZER INC. | 2014-11-11 | — | — | US | disclosed |
| EP-1784183-B1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER (US) | 2012-01-25 | — | — | EP | disclosed |
| US-20090023924-A1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER INC. | 2009-01-22 | — | — | US | disclosed |
| EP-1784183-A2 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | Pfizer Products Incorporated (US) | 2007-05-16 | — | — | EP | disclosed |
| WO-2006026034-A2 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2006-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023924-A1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | CYP3A4, CYP3A43, CYP2F1 | KDR 2551/4885PDGFRB 3219/4885FLT1 832/4885 |
| US-20150065726-A1 | PROCESSES FOR THE PREPARATION OF ISOTHIAZOLE DERIVATIVES | CYP3A4, CYP3A43, CYP2F1 | KDR 2246/4885PDGFRB 3147/4885FLT1 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.